Real‐world evaluation of the NHS testing criteria for glucokinase hyperglycaemia in pregnancy
Diabetic Medicine · 13.11.2026
DOI: 10.1111/dme.70531 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetic Medicine, online erschienen am 13.11.2026. Verfasst von Olivia Jones und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Endocrinology, Royal Sussex County Hospital, Brighton, UK. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Aims
Criteria for Glucokinase‐Maturity Onset Diabetes of the Young (GCK‐MODY) genetic testing are now being integrated into the National Health Service (NHS) services using fasting glucose, body mass index (BMI) and ethnicity. We aimed to assess the national screening criteria for GCK‐MODY in a multi‐ethnic population.
Methods
GCK‐MODY testing was offered to women with gestational diabetes that met criteria in a multi‐ethnic cohort. Data from the national testing centre was used to compare patient characteristics in those positive and negative for GCK‐MODY.
Results
Fewer cases of GCK‐MODY were found when testing using NHS criteria (0.14%) than expected (0.9%). Individuals testing positive for GCK‐MODY had a higher HbA1c than negative individuals ( p < 0.001). There was no difference in 2‐h glucose increment ( p = 0.829).
Conclusions
Current criteria may not effectively identify a high‐risk cohort of individuals to test, given the prevalence of GCK‐MODY in those tested, leading to over‐testing. HbA1c may prove a useful additional screening parameter. Further studies are needed to improve the criteria's utility across different ethnicities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diabetes and Endocrinology, Royal Sussex County Hospital, Brighton, UK.
- Department of Diabetes & Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
- Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.
- University of Exeter Medical School, Exeter, UK.
- University of Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK.
- NIHR Oxford Biomedical Research Centre, Oxford University Hospital Foundation Trust, Oxford, UK.
ORCID-Profile: Olivia Jones, Anna Brackenridge, Jayne Houghton, Katharine R Owen, Sara L White, Ali J Chakera
Zitieren
APA
Jones, O., Brackenridge, A., Houghton, J., Owen, K. R., White, S. L., & Chakera, A. J. (2026). Real‐world evaluation of the NHS testing criteria for glucokinase hyperglycaemia in pregnancy. Diabetic Medicine. https://doi.org/10.1111/dme.70531
Vancouver
Jones O, Brackenridge A, Houghton J, Owen KR, White SL, Chakera AJ. Real‐world evaluation of the NHS testing criteria for glucokinase hyperglycaemia in pregnancy. Diabetic Medicine. 2026. doi:10.1111/dme.70531
BibTeX
@article{Jones2026,
author = {Jones, Olivia and Brackenridge, Anna and Houghton, Jayne and Owen, Katharine R and White, Sara L and Chakera, Ali J},
title = {Real‐world evaluation of the NHS testing criteria for glucokinase hyperglycaemia in pregnancy},
journal = {Diabetic Medicine},
year = {2026},
doi = {10.1111/dme.70531}
}
EUVIMED